Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Inside the Lab Hematology, Point of care testing, Technology and innovation

“Lab in a Needle” a Not Too Distant Reality?

What if the needle and syringe used to take a blood draw could also process and analyze the sample, and (with the help of a fluorescence detection system) display the test result? An international group of researchers believe they can make the self-contained “lab in a needle” a reality with the help of microfluidics technology.

“We used the concept of lab on a chip, which compresses the entire function of a laboratory diagnostic test onto a tiny microfluidics chip, to create lab in a needle,” says Stephen Wong, chair of Systems Medicine and Bioengineering at Houston Methodist Research Institute, Texas, US, and co-author of the associated paper (1). “Our goal is to integrate sample acquisition and preparation into one device, a significant challenge that has slowed the development of point-of-care testing,” he added.

The prototype device is the first of its kind to integrate all the steps needed to process a sample for hepatotoxicity testing. Made up of two modules (see Figure 1), the system contains a chip which prepares the sample by performing tissue lysis and purifying mRNA. The second chip performs quantitative reverse transcriptase PCR in order to carry out gene expression analysis for two biomarkers associated with liver toxicity; alanine transaminase (ALT) and aspartate transaminase (AST).

In an initial study of the device, liver samples of mice which had been dosed with the alkylating agent cyclophosphamide were analyzed. The researchers found that increased dosage with the drug could be correlated with increased expression of ALT and AST, which could be detected by their prototype. The device is not yet fully self-contained, and currently requires external instrumentation, but the team plans to create a smaller, more integrated version that could be used to test liver function in outpatients, in patients’ homes, or even in the field.

It goes without saying that an accurate point-of-care hepatotoxicity test could be incredibly beneficial, in particular given that current tests for liver function can take days to return a result, while the prototype “lab in a needle” could theoretically do it in just 30 minutes. The technology could also be applied to a range of lab tests, shortening the time it takes to get results and potentially bringing traditional lab tests to underserved areas, says Wong. He acknowledges that this is a disruptive technology, admitting that, “We actually move all the people-processing steps into the box, and automate them.” Further research with the prototype is ongoing, and if successful – as with most point-of-care devices – the assumption is that it would be complementary, rather than a replacement, to standard lab testing.

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. GS Lim, et al., “A lab-on-a-chip system integrating tissue sample preparation and multiplex RT-qPCR for gene expression analysis in point-of-care hepatotoxicity assessment”, Lab Chip, 15, 4032–4043, (2015). PMID: 26329655.
About the Author
Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as an Associate Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

Related Application Notes
ClearLLab 10C Panel Markers and how they are combined

| Contributed by Beckman Coulter Life Sciences

ClearLLab Control Cells - A Process Control for ClearLLab 10C Application

| Contributed by Beckman Coulter Life Sciences

The Analysis of FFPE Samples by Next-Generation Sequencing (NGS) of Key Genes for Research into Breast and Ovarian Cancer

| Contributed by Oxford Gene Technology

Most Popular
Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register